Voyager Therapeutics Inc To Discuss Strategic Collaboration With Neurocrine Biosciences Inc Call Transcript

Jan 09, 2023 / 01:45PM GMT
Operator

Good morning, and welcome to Voyager Therapeutics conference call to discuss today's announcement of a strategic collaboration with Neurocrine Biosciences. (Operator Instructions) Please be advised that this call is being recorded at the company's request. A replay of today's call will be available on the Investors section of the company's website approximately 2 hours after completion of this call. I would now like to turn the call over to Pete Pfreundschuh, Chief Financial Officer. Please go ahead.

Peter P. Pfreundschuh - Voyager Therapeutics, Inc. - CFO

Thank you, and good morning. Earlier this morning, we issued a joint press release with Neurocrine, announcing a strategic collaboration between the 2 companies for the development and commercialization of Voyager's GBA1 program, 3 additional CNS rare disease gene therapy targets. This press release is available on our website.

On today's call, we will review highlights from the strategic collaboration and discuss the transformational value that this brings Voyager. We will also provide an update on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot